1 of LA BioMed's founders to be honored

November 25, 2009

LOS ANGELES (Nov. 25, 2009) - Melvin R. Kaplan, MD, FACP, a former Board Chair and one of the founders of the research institute that became Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), will be honored by the American College of Physicians for his lifetime devotion to the care of patients.

At its April 22, 2010 meeting in Toronto, the American College of Physicians will present Dr. Kaplan with the Ralph O. Claypoole Sr. Memorial Award for Devotion of a Career in Internal Medicine to the Care of Patients, an honor it said it bestows annually on "an outstanding practitioner of internal medicine." The organization said the honoree must be "highly respected" by his peers and have served as a "role model" for others.

"The competition for this award was extremely stiff, but your contributions were the most outstanding," said Faith T. Fitzgerald, MD, MACP, chair of the American College of Physicians Award Committee, in the letter notifying Dr. Kaplan of his award. "We look forward to acknowledging your stellar career."

Dr. Kaplan has been affiliated with Harbor-UCLA Medical Center since 1950, including serving five years as chief of medicine. He continues to serve as a clinical professor of medicine at David Geffen School of Medicine at UCLA. He also served on the committee that recommended the creation of a research institute on Harbor-UCLA Medical Center's campus, the institute that became LA BioMed. In addition, he served as president and chair of the board of directors at the institute from 1978 to 1981.

LA BioMed honored him in 2004 as one of its "Legends," and he's received numerous awards over his career, including the Lifetime Distinguished Service Award, the Distinguished Service and Leadership Award and the Distinguished Teaching Award, all from Harbor-UCLA Medical Center. The Los Angeles County Board of Supervisors also recognized his service in 2002 with a commendation, and the National Management Association presented him with the Silver Knight of Management Award in 1980.

"Congratulations to Dr. Kaplan for this wonderful recognition of the care he's provided patients for more than 60 years," said LA BioMed President and CEO David I. Meyer, PhD. "Dr. Kaplan was among the visionaries who saw the potential for creating a research institute on the Harbor-UCLA Medical Center campus. Because of their vision, LA BioMed is thriving today and leading the way in taking discoveries from the bench side to the bedside."
About the American College of Physicians

The American College of Physicians (ACP) is a national organization of internists -- physicians who specialize in the prevention, detection and treatment of illnesses in adults. ACP is the largest medical-specialty organization and second-largest physician group in the United States. Its membership of 129,000 includes internists, internal medicine subspecialists, medical students, residents and fellows.

About LA BioMed

Founded in 1952, LA BioMed at Harbor-UCLA Medical Center is one of the country's largest nonprofit independent biomedical research institutes. It conducts biomedical research, trains young scientists and provides community services, including childhood immunization and nutrition assistance. The institute's researchers conduct studies in such areas as cardiovascular disease, emerging infections, cancer, diabetes, kidney disease, dermatology, reproductive health, vaccine development, respiratory disorders, inherited illnesses and neonatology. LA BioMed is academically affiliated with the David Geffen School of Medicine at UCLA. For more information, please visit our website at www.LABioMed.org

LA BioMed

Related Internal Medicine Articles from Brightsurf:

COVID-19 news from Annals of Internal Medicine
In this Ideas and Opinions piece from the University of California, San Francisco and San Francisco Veterans Affairs Medical Center, the authors discuss the findings of early studies that addressed the use of chest computed tomography for the detection of COVID-19.

New COVID-19 content from Annals of Internal Medicine
Below please find links to new coronavirus-related content published today in Annals of Internal Medicine.

Changes in internal medicine subspecialty choices of women, men
This study used enrollment data to examine changes in the internal medicine subspecialty choices of women and men from 1991 to 2016.

Do internal medicine residents feel bullied during training?
This research letter uses survey data to report on perceived bullying by internal medicine residents during training.

Annals publishes annual updates in internal medicine
Annals of Internal Medicine, the flagship journal of the American College of Physicians (ACP), has published summaries of the most important medical studies published in 2016 in the fields of general internal medicine, cardiology, hematology, endocrinology, gastroenterology and hepatology, rheumatology, and perioperative, pulmonary, and geriatric medicine.

News from Annals of Internal Medicine April 7, 2015
In the next issue of Annals of Internal Medicine are: Weight Watchers and Jenny Craig come out on top among commercial weight loss programs; Physical therapy as effective as surgery for lumber spinal stenosis; and Leading internists call for more thoughtful use of CPR.

News from Annals of Internal Medicine March 31, 2015
Articles include: USPSTF reviews evidence to update recommendations on iron supplementation and deficiency screening in pregnant women; New hep C treatments are cost-effective for some patients, yet may exceed insurers' willingness to pay.

News from Annals of Internal Medicine March 24, 2015
The US Preventive Services Task Force concludes that the current evidence is insufficient to recommend for or against screening for thyroid dysfunction in nonpregnant, asymptomatic adults.

News from Annals of Internal Medicine Feb. 10, 2015
Using Lung Imaging Reporting and Data System (Lung-RADS) criteria developed by the American College of Radiology to interpret low-dose CT lung screening results may reduce false positives compared to the National Lung Screening Trial, but the trade-off is reduced sensitivity, according to an article published in Annals of Internal Medicine.

News from Dec. 23, 2014, Annals of Internal Medicine
The Dec. 23, 2014, issue of Annals of Internal Medicine includes 'Blood pressure drugs likely to prevent stroke and death in patients with mild hypertension' and 'Task force reviews evidence to update blood pressure screening recommendations.'

Read More: Internal Medicine News and Internal Medicine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.